Genetically-determined hyperfunction of the S100B/RAGE axis is a risk factor for aspergillosis in stem cell transplant recipients.

Invasive aspergillosis (IA) is a major threat to the successful outcome of hematopoietic stem cell transplantation (HSCT), although individual risk varies considerably. Recent evidence has established a pivotal role for a danger sensing mechanism implicating the S100B/receptor for advanced glycation...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Cristina Cunha, Gloria Giovannini, Antonio Pierini, Alain S Bell, Guglielmo Sorci, Francesca Riuzzi, Rosario Donato, Fernando Rodrigues, Andrea Velardi, Franco Aversa, Luigina Romani, Agostinho Carvalho
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2011
Materias:
R
Q
Acceso en línea:https://doaj.org/article/985cef9f6e544e378f08b8bcde2228c8
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:985cef9f6e544e378f08b8bcde2228c8
record_format dspace
spelling oai:doaj.org-article:985cef9f6e544e378f08b8bcde2228c82021-11-18T07:33:58ZGenetically-determined hyperfunction of the S100B/RAGE axis is a risk factor for aspergillosis in stem cell transplant recipients.1932-620310.1371/journal.pone.0027962https://doaj.org/article/985cef9f6e544e378f08b8bcde2228c82011-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22114731/?tool=EBIhttps://doaj.org/toc/1932-6203Invasive aspergillosis (IA) is a major threat to the successful outcome of hematopoietic stem cell transplantation (HSCT), although individual risk varies considerably. Recent evidence has established a pivotal role for a danger sensing mechanism implicating the S100B/receptor for advanced glycation end products (RAGE) axis in antifungal immunity. The association of selected genetic variants in the S100B/RAGE axis with susceptibility to IA was investigated in 223 consecutive patients undergoing HSCT. Furthermore, studies addressing the functional consequences of these variants were performed. Susceptibility to IA was significantly associated with two distinct polymorphisms in RAGE (-374T/A) and S100B (+427C/T) genes, the relative contribution of each depended on their presence in both transplantation counterparts [patient SNP(RAGE), adjusted hazard ratio (HR), 1.97; P = 0.042 and donor SNP(RAGE), HR, 2.03; P = 0.047] or in donors (SNP(S100B), HR, 3.15; P = 7.8e-(4)) only, respectively. Functional assays demonstrated a gain-of-function phenotype of both variants, as shown by the enhanced expression of inflammatory cytokines in RAGE polymorphic cells and increased S100B secretion in vitro and in vivo in the presence of the S100B polymorphism. These findings point to a relevant role of the danger sensing signaling in human antifungal immunity and highlight a possible contribution of a genetically-determined hyperfunction of the S100B/RAGE axis to susceptibility to IA in the HSCT setting.Cristina CunhaGloria GiovanniniAntonio PieriniAlain S BellGuglielmo SorciFrancesca RiuzziRosario DonatoFernando RodriguesAndrea VelardiFranco AversaLuigina RomaniAgostinho CarvalhoPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 6, Iss 11, p e27962 (2011)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Cristina Cunha
Gloria Giovannini
Antonio Pierini
Alain S Bell
Guglielmo Sorci
Francesca Riuzzi
Rosario Donato
Fernando Rodrigues
Andrea Velardi
Franco Aversa
Luigina Romani
Agostinho Carvalho
Genetically-determined hyperfunction of the S100B/RAGE axis is a risk factor for aspergillosis in stem cell transplant recipients.
description Invasive aspergillosis (IA) is a major threat to the successful outcome of hematopoietic stem cell transplantation (HSCT), although individual risk varies considerably. Recent evidence has established a pivotal role for a danger sensing mechanism implicating the S100B/receptor for advanced glycation end products (RAGE) axis in antifungal immunity. The association of selected genetic variants in the S100B/RAGE axis with susceptibility to IA was investigated in 223 consecutive patients undergoing HSCT. Furthermore, studies addressing the functional consequences of these variants were performed. Susceptibility to IA was significantly associated with two distinct polymorphisms in RAGE (-374T/A) and S100B (+427C/T) genes, the relative contribution of each depended on their presence in both transplantation counterparts [patient SNP(RAGE), adjusted hazard ratio (HR), 1.97; P = 0.042 and donor SNP(RAGE), HR, 2.03; P = 0.047] or in donors (SNP(S100B), HR, 3.15; P = 7.8e-(4)) only, respectively. Functional assays demonstrated a gain-of-function phenotype of both variants, as shown by the enhanced expression of inflammatory cytokines in RAGE polymorphic cells and increased S100B secretion in vitro and in vivo in the presence of the S100B polymorphism. These findings point to a relevant role of the danger sensing signaling in human antifungal immunity and highlight a possible contribution of a genetically-determined hyperfunction of the S100B/RAGE axis to susceptibility to IA in the HSCT setting.
format article
author Cristina Cunha
Gloria Giovannini
Antonio Pierini
Alain S Bell
Guglielmo Sorci
Francesca Riuzzi
Rosario Donato
Fernando Rodrigues
Andrea Velardi
Franco Aversa
Luigina Romani
Agostinho Carvalho
author_facet Cristina Cunha
Gloria Giovannini
Antonio Pierini
Alain S Bell
Guglielmo Sorci
Francesca Riuzzi
Rosario Donato
Fernando Rodrigues
Andrea Velardi
Franco Aversa
Luigina Romani
Agostinho Carvalho
author_sort Cristina Cunha
title Genetically-determined hyperfunction of the S100B/RAGE axis is a risk factor for aspergillosis in stem cell transplant recipients.
title_short Genetically-determined hyperfunction of the S100B/RAGE axis is a risk factor for aspergillosis in stem cell transplant recipients.
title_full Genetically-determined hyperfunction of the S100B/RAGE axis is a risk factor for aspergillosis in stem cell transplant recipients.
title_fullStr Genetically-determined hyperfunction of the S100B/RAGE axis is a risk factor for aspergillosis in stem cell transplant recipients.
title_full_unstemmed Genetically-determined hyperfunction of the S100B/RAGE axis is a risk factor for aspergillosis in stem cell transplant recipients.
title_sort genetically-determined hyperfunction of the s100b/rage axis is a risk factor for aspergillosis in stem cell transplant recipients.
publisher Public Library of Science (PLoS)
publishDate 2011
url https://doaj.org/article/985cef9f6e544e378f08b8bcde2228c8
work_keys_str_mv AT cristinacunha geneticallydeterminedhyperfunctionofthes100brageaxisisariskfactorforaspergillosisinstemcelltransplantrecipients
AT gloriagiovannini geneticallydeterminedhyperfunctionofthes100brageaxisisariskfactorforaspergillosisinstemcelltransplantrecipients
AT antoniopierini geneticallydeterminedhyperfunctionofthes100brageaxisisariskfactorforaspergillosisinstemcelltransplantrecipients
AT alainsbell geneticallydeterminedhyperfunctionofthes100brageaxisisariskfactorforaspergillosisinstemcelltransplantrecipients
AT guglielmosorci geneticallydeterminedhyperfunctionofthes100brageaxisisariskfactorforaspergillosisinstemcelltransplantrecipients
AT francescariuzzi geneticallydeterminedhyperfunctionofthes100brageaxisisariskfactorforaspergillosisinstemcelltransplantrecipients
AT rosariodonato geneticallydeterminedhyperfunctionofthes100brageaxisisariskfactorforaspergillosisinstemcelltransplantrecipients
AT fernandorodrigues geneticallydeterminedhyperfunctionofthes100brageaxisisariskfactorforaspergillosisinstemcelltransplantrecipients
AT andreavelardi geneticallydeterminedhyperfunctionofthes100brageaxisisariskfactorforaspergillosisinstemcelltransplantrecipients
AT francoaversa geneticallydeterminedhyperfunctionofthes100brageaxisisariskfactorforaspergillosisinstemcelltransplantrecipients
AT luiginaromani geneticallydeterminedhyperfunctionofthes100brageaxisisariskfactorforaspergillosisinstemcelltransplantrecipients
AT agostinhocarvalho geneticallydeterminedhyperfunctionofthes100brageaxisisariskfactorforaspergillosisinstemcelltransplantrecipients
_version_ 1718423302625558528